Sierra Oncology, Inc. Skyrocketed
Thu, Apr 14, 2022 at 05:30 PM
Sierra Oncology, Inc. (SRRA:NASDAQ) jumped higher at $54.75, a gain of 38.5%. On Wed, Apr 13, 2022, SRRA:NASDAQ hit a New 2-Week High of $54.75. The stock appeared on our News Catalysts scanner on Thu, Apr 14, 2022 at 04:46 PM in the 'BIOTECH' category. From Wed, Mar 30, 2022, the stock recorded 80.00% Up Days and 63.64% Green Days
About Sierra Oncology, Inc. (SRRA:NASDAQ)
Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.
Top 10 Gainers:
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 69.23%
- Kaleido Biosciences, Inc. (KLDO:NASDAQ), 68.6%
- Veru Inc. (VERU:NASDAQ), 49.35%
- Antares Pharma, Inc. (ATRS:NASDAQ), 48.66%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 46.24%
- Houston American Energy Corp. (HUSA:NYSEMKT), 42.94%
- MedAvail Holdings Inc. (MDVL:NASDAQ), 40.63%
- HighPeak Energy Inc. (HPK:NASDAQ), 39.76%
- Creatd Inc. (CRTD:NASDAQ), 39.43%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 38.54%